CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma Response by Activating Unlicensed NK Cells-Reference-Cited by-同舟云学术

CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma Response by Activating Unlicensed NK Cells

Published:2014-06-23 Issue:9 Volume:2 Page:878-889
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Du Juan,Lopez-Verges Sandra,Pitcher Brandelyn N.,Johnson Jeffrey,Jung Sin-Ho,Zhou Lili,Hsu Katharine,Czuczman Myron S.,Cheson Bruce,Kaplan Lawrence,Lanier Lewis L.,Venstrom Jeffrey M.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. O-GlcNAc Modification Is a Promising Therapeutic Target for Diabetic Retinopathy;International Journal of Molecular Sciences;2024-06-06

2. KIR2DS1 and KIR2DL1-C245 Dominantly Repress NK Cell Degranulation Triggered by Monoclonal or Bispecific Antibodies, whereas Education by Uptuning Inhibitory Killer Ig-related Receptors Exerts No Advantage in Ab-dependent Cellular Cytotoxicity;The Journal of Immunology;2024-01-19

3. The Influence of KIR Gene Polymorphisms and KIR-ligand Binding on Outcomes in Hematologic Malignancies following Haploidentical Stem Cell Transplantation: A Comprehensive Review;Current Cancer Drug Targets;2023-12

4. Prognostic impact of absolute peripheral blood NK cell count after four cycles of R-CHOP-like regimen treatment in patients with diffuse large B cell lymphoma;Clinical and Experimental Medicine;2023-11-08

5. Evaluation of KIR3DL1/KIR3DS1 allelic polymorphisms in Kenyan children with endemic Burkitt lymphoma;PLOS ONE;2023-08-30